CliffBio
small molecule

TRISENOX

ARSENIC TRIOXIDE

Loss of exclusivity—loss of exclusivity
CompanyCephalon →See this company's full patent-cliff portfolio

Drug detail

Brand nameTRISENOX
Active ingredientARSENIC TRIOXIDE
Strength1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalSeptember 2000
Marketing statusDISCN

More from Cephalon

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.